Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer

CD90 is used as a marker for cancer stem cell in liver cancer. We aimed to study the mechanism by which CD90 promoted liver cancer progression and identify the new therapeutic targets on CD90 signal pathway. Ectopic expression of CD90 in liver cancer cell lines enhanced anchorage-independent growth...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncotarget
Hauptverfasser: Chen, Wei-Ching, Chang, Yung-Sheng, Hsu, Hui-Ping, Yen, Meng-Chi, Huang, Hau-Lun, Cho, Chien-Yu, Wang, Chih-Yang, Weng, Tzu-Yang, Lai, Po-Ting, Chen, Ching-Shih, Lin, Yih-Jyh, Lai, Ming-Derg
Format: Artigo
Sprache:Inglês
Veröffentlicht: Impact Journals LLC 2015
Schlagworte:
Research Paper
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4767481/
https://ncbi.nlm.nih.gov/pubmed/26556861
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge